We are live on ! Find out more
VM

VV Manager Portfolio holdings

AUM $114M
1-Year Est. Return 59.16%
This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+59.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$134M
AUM Growth
-$50M
Cap. Flow
-$51.2M
Cap. Flow %
-38.07%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ALLO icon
Allogene Therapeutics
ALLO
+$51.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLO icon
1
Allogene Therapeutics
ALLO
$618M
$111M 82.89%
4,087,521
-1,796,805
-31% -$51.2M
QTTB icon
2
Q32 Bio
QTTB
$346M
$14M 10.38%
42,825
STRO icon
3
Sutro Biopharma
STRO
$391M
$9.05M 6.73%
99,558

Similar funds

VV Manager's Q3 2019 Portfolio in Review

As of Q3 2019, VV Manager held 3 positions worth $134M, down 27% from $184M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

VV Manager withdrew a net $51.2M in Q3 2019, reducing 1 holding. Its largest reduction was Allogene Therapeutics, cutting an estimated $51.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • VV Manager's biggest Q3 2019 reduction was Allogene Therapeutics, cutting an estimated $51.2M.
  • VV Manager's ten largest holdings make up 100% of its $134M portfolio in Q3 2019.
  • VV Manager opened 0 new positions and closed 0 in Q3 2019.
  • VV Manager's portfolio value fell 27% quarter-over-quarter to $134M.

Based on VV Manager's 13F filing for Q3 2019, filed 15 Oct 2019.